Rx Safes strengthens intellectual property protection for Rx SafeDOSE through another patent acquisition.
M2 EQUITYBITES-November 13, 2015-Rx Safes strengthens intellectual property protection for Rx SafeDOSE through another patent acquisition
(C)2015 M2 COMMUNICATIONS http://www.m2.com
Healthcare security company Rx Safes (OTC PINK:RXSF) revealed on Thursday the completion of the acquisition of an additional patent to further expand its intellectual property portfolio, protecting its Rx SafeDOSE, Patient Controlled Analgesia pendant.
The patent inventor, Phillip Jurson, MD, a nationally renowned anesthesiologist and pain management physician, was awarded patent number 7,806,852 -- method and apparatus for patient-controlled medical therapeutics utilising biometrics in a patient controlled administration of pain medications, with a priority date in April 2006.
This patent strengthens the company's intellectual property surrounding its Rx SafeDOSE product. The patent includes claims that cover additional control features on the pendant, which will provide a greater level of safety for patients and allow Rx Safes the ability to corner the market for the secure patient administration of medications.
According to the company, there are in excess of 600,000 PCA Pendants in use in hospitals throughout the US alone, and this does not consider usage in the home or in assisted living/nursing facilities. These devices have a short operating lifespan and are typically replaced every 10 to 14 months.
Through developing and acquiring product specific intellectual property, the company strengthens its ability to protect its innovative products from competition as it continue to establish Rx Safes as the trusted brand in biometric products for healthcare.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Nov 13, 2015|
|Previous Article:||Monogram Residential Trust announces Q4 2015 dividend of USD0.075 per share.|
|Next Article:||Ally Financial redeems all remaining 1.3m series G preferred shares at USD1,005.64 per share.|